A detailed history of Guyasuta Investment Advisors Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Guyasuta Investment Advisors Inc holds 172,952 shares of BDX stock, worth $39.5 Million. This represents 2.76% of its overall portfolio holdings.

Number of Shares
172,952
Previous 152,072 13.73%
Holding current value
$39.5 Million
Previous $35.5 Million 17.33%
% of portfolio
2.76%
Previous 2.45%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$221.47 - $242.41 $4.62 Million - $5.06 Million
20,880 Added 13.73%
172,952 $41.7 Million
Q2 2024

Jul 22, 2024

SELL
$225.07 - $246.17 $563,800 - $616,655
-2,505 Reduced 1.62%
152,072 $35.5 Million
Q1 2024

Apr 16, 2024

SELL
$233.45 - $247.73 $148,707 - $157,804
-637 Reduced 0.41%
154,577 $38.3 Million
Q4 2023

Feb 05, 2024

SELL
$232.24 - $267.23 $32,745 - $37,679
-141 Reduced 0.09%
155,214 $37.8 Million
Q3 2023

Oct 25, 2023

BUY
$254.9 - $283.59 $147,587 - $164,198
579 Added 0.37%
155,355 $40.2 Million
Q2 2023

Jul 17, 2023

SELL
$238.39 - $265.32 $57,213 - $63,676
-240 Reduced 0.15%
154,776 $40.9 Million
Q1 2023

Apr 28, 2023

BUY
$229.71 - $259.35 $147,473 - $166,502
642 Added 0.42%
155,016 $38.4 Million
Q4 2022

Jan 30, 2023

BUY
$218.29 - $256.91 $203,446 - $239,440
932 Added 0.61%
154,374 $39.3 Million
Q3 2022

Oct 25, 2022

BUY
$51.03 - $264.23 $56,184 - $290,917
1,101 Added 0.72%
153,442 $34.2 Million
Q2 2022

Jul 21, 2022

BUY
$234.74 - $275.42 $395,067 - $463,531
1,683 Added 1.12%
152,341 $37.6 Million
Q1 2022

May 03, 2022

SELL
$243.64 - $270.48 $216,595 - $240,456
-889 Reduced 0.59%
150,658 $40.1 Million
Q4 2021

Feb 08, 2022

SELL
$230.08 - $250.94 $233,531 - $254,704
-1,015 Reduced 0.67%
151,547 $38.1 Million
Q3 2021

Nov 09, 2021

SELL
$232.72 - $256.47 $85,175 - $93,868
-366 Reduced 0.24%
152,562 $37.5 Million
Q2 2021

Aug 12, 2021

BUY
$232.65 - $254.58 $576,972 - $631,358
2,480 Added 1.65%
152,928 $37.2 Million
Q1 2021

May 11, 2021

BUY
$232.09 - $256.88 $62,432 - $69,100
269 Added 0.18%
150,448 $36.6 Million
Q4 2020

Feb 08, 2021

BUY
$221.92 - $245.94 $121,612 - $134,775
548 Added 0.37%
150,179 $37.6 Million
Q3 2020

Oct 28, 2020

BUY
$215.77 - $276.76 $63,004 - $80,813
292 Added 0.2%
149,631 $34.8 Million
Q2 2020

Aug 06, 2020

BUY
$219.9 - $263.41 $717,313 - $859,243
3,262 Added 2.23%
149,339 $35.7 Million
Q1 2020

Apr 28, 2020

BUY
$195.69 - $279.01 $85,516 - $121,927
437 Added 0.3%
146,077 $33.6 Million
Q4 2019

Feb 10, 2020

BUY
$236.45 - $266.82 $136,668 - $154,221
578 Added 0.4%
145,640 $39.6 Million
Q3 2019

Nov 08, 2019

SELL
$230.58 - $256.08 $417,810 - $464,016
-1,812 Reduced 1.23%
145,062 $35.8 Million
Q2 2019

Aug 06, 2019

BUY
$217.4 - $246.08 $1.18 Million - $1.33 Million
5,423 Added 3.83%
146,874 $37 Million
Q1 2019

May 10, 2019

SELL
$206.05 - $248.17 $441,153 - $531,331
-2,141 Reduced 1.49%
141,451 $35.3 Million
Q4 2018

Feb 11, 2019

BUY
$204.73 - $257.93 $353,978 - $445,960
1,729 Added 1.22%
143,592 $32.4 Million
Q3 2018

Nov 08, 2018

SELL
$233.07 - $256.0 $268,030 - $294,400
-1,150 Reduced 0.8%
141,863 $37 Million
Q2 2018

Aug 07, 2018

BUY
$208.1 - $233.85 $4,578 - $5,144
22 Added 0.02%
143,013 $34.3 Million
Q1 2018

May 09, 2018

SELL
$205.46 - $240.27 $1.1 Million - $1.28 Million
-5,330 Reduced 3.59%
142,991 $31 Million
Q4 2017

Feb 12, 2018

SELL
$189.0 - $222.64 $35,154 - $41,411
-186 Reduced 0.13%
148,321 $31.8 Million
Q3 2017

Nov 09, 2017

SELL
$186.89 - $198.9 $124,094 - $132,069
-664 Reduced 0.45%
148,507 $29.1 Million
Q2 2017

Aug 09, 2017

BUY
N/A
149,171
149,171 $29.1 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Guyasuta Investment Advisors Inc Portfolio

Follow Guyasuta Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guyasuta Investment Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guyasuta Investment Advisors Inc with notifications on news.